No association seen for changes in immediate or delayed memory

Clinical and cost-effectiveness superior compared with practitioner-supported cognitive behavioral therapy

Low or very low confidence in evidence for reduced pain intensity after treatment with various meds, med combos

Before pandemic, more evaluations and identifications seen by age 48 months per 1,000 children aged 4 years versus children aged 8 years

Participants with lower bone mineral density at femoral neck more likely to develop all-cause dementia, Alzheimer disease during follow-up

Standardized mortality rate increased for those receiving monotherapy, those receiving four or more meds, those without comorbidities

Recovery of hearing mostly affected by cervical-vestibular evoked myogenic potentials impairment and number of involved receptors

Faster cognitive decline seen for older adults with both conditions

Insomnia was more consistently associated with worries about the pandemic than exposure to COVID-19 risk factors

Prevalence lower among non-Hispanic Whites and children of two or more races versus Blacks, Hispanics, Asian/Pacific Islanders